Cellular pharmacology of P-ethoxy antisense oligonucleotides targeted to Bcl-2 in a follicular lymphoma cell line

Leukemia and Lymphoma

Volumn 44, Issue 11, 2003, Pages 1979-1985

  Gutiérrez Puente, Yolanda ^a,b   Tari, Ana M ^a   Ford, Richard J ^a   Tamez Guerra, Reyes ^b   Mercado Hernandez, Roberto ^b   Santoyo Stephano, Martha ^b   Lopez Berestein, Gabriel ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Bcl 2 antisense; Cellular pharmacology; Follicular lymphoma; Liposomes; Oligonucleotides

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPOSOME; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

ARTICLE; CELL GROWTH; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE DELIVERY SYSTEM; GENE SEQUENCE; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SEQUENCE ANALYSIS; TRANSLATION INITIATION; WESTERN BLOTTING;

CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; DRUG DELIVERY SYSTEMS; ETHYL ETHERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; HUMANS; LIPOSOMES; LYMPHOMA, FOLLICULAR; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0242719919     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000099733     Document Type: Article

References (23)

1. Reed, J.C. (1997) "Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies", Seminars in Hematology 34, 9-19.
2. Lin, Y., Lu, L. and Hu, J. (1999) "Inhibition of Bcl-2 expression in HL60 cells by incubation with antisense phosphorothioate oligodeoxynucleotides", Chung-Hua i Hsueh i Chuan Hsueh Tsa Chih 16, 12-15.
3. Raynaud, F., Orr, R., Goddard, P., Lacely, H., Lancashire, H., Judson, I., Beck, T., Bryan, B. and Cotter, F. (1997) "Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to Bcl-2, after intravenous administration or continuous subcutaneous infusion to mice", Journal of Pharmacology and Experimental Therapeutics 281, 420-427.
4. Waters, J.S. (2000) "Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma [see comments]", Journal of Clinical Oncology 18, 1812-1823.
5. Stein, C.A. and Cheng, Y.C. (1993) "Antisense oligonucleotides as therapeutic agents - is the bullet really magical?", Science 261, 1004-1012.
6. Matteucci, M. (1997) "Oligonucleotide analogues: an overview", Ciba Foundation Symposium 209, 5-14, Discussion 14-8.
7. Tari, A. and Lopez-Berestein, G. (1997) "Oligonucleotide therapy for hematological malignancies", Journal of Liposomal Research 7, 19-30.
8. Tormo, M., Tari, A.M., McDonnell, T.J., Cabanillas, F., Garcia-Conde, J. and Lopez-Berestein, G. (1998) "Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation", Leukemia and Lymphoma 30, 367-379.
9. Campbell, J.M., Bacon, T.A. and Wickstrom, E. (1990) "Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid", Journal of Biochemical and Biophysical Methods 20, 259-267.
10. Ollikainen, H., Lappalainen, K., Jaaskelainen, I., Syrjanen, S. and Pulkki, K. (1996) "Liposomal targeting of Bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines", Leukemia and Lymphoma 24, 165-174.
11. Zamecnik, P.C. and Stephenson, M.L. (1978) "Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide", Proceedings of the National Academy of Sciences of the United States of America 75, 280-284.
12. Blake, K.R., Murakami, A. and Miller, P.S. (1985) "Inhibition of rabbit globin mRNA translation by sequence-specific oligodeoxyribonucleotides", Biochemistry 24, 6132-6138.
13. Cazenave, C., Loreau, N., Thuong, N.T., Toulme, J.J. and Helene, C. (1987) "Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynuclectides covalently linked to intercalating agents", Nucleic Acids Research 15, 4717-4736.
14. Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J.S. and Broder, S. (1987) "Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus", Proceedings of the National Academy of Sciences of the United States of America 84, 7706-7710.
15. Miller, P., Agris, C., Aurelian, A., Blake, K., Murakami, M., Reddy, P., Spitz, S. and Ts'o, P. (1985) "Control of ribonucleic acid function by oligonucleoside methylphosphonates", Biochimie 67, 769-776.
16. Morvan, F., Rayner, B., Imbach, J.L., Chang, D.K. and Lown, J.W. (1987) "Alpha-DNA-III. Characterization by high field 1H-NMR, anti-parallel self-recognition and conformation of the unnatural hexadeoxyribonucleotides alpha-[d(CpApTpGpCpG)] and alpha-[d(CpGpCpApTpG)]. Alpha-oligodeoxynucleotides as potential cellular probes for gene control", Nucleic Acids Research 15, 4241-4255.
17. Beham, A., Marin, M., Fernandez, A., Hermann, J., Brisbay, S., Tari, A., Lopez-Berestein, G., Lozano, G., Sarkiss, M. and McDonnell, T. (1997) "Bcl-2 inhibits p53 nuclear import following DNA damage", Oncogene 15, 2767-2772.
18. Gutierrez-Puente, Y., Tari, A.M., Stephens, C., Rosenblum, M., Guerra, R.T. and Lopez-Berestein, G. (1999) "Safety, pharmacokinetics, and tissue distribution of liposomal P-ethoxy antisense oligonucleotides targeted to Bcl-2", Journal of Pharmacology and Experimental Therapeutics 291, 865-869.
19. Tari, A., Stephens, C., Rosenblum, M. and Lopez-Berestein, G. (1998) "Pharmacokinetics, tissue distribution and safety of P-ethoxy oligonucleotides incorporated in liposomes", Journal of Liposome Research 8, 251-264.
20. Zar, J.H. (1999) Biostatistical Analysis, 4th Ed. (Prentice Hall, New Jersey).
21. Tari, A., Andreeff, M., Kleine, H. and Lopez-Berestein, G. (1996) "Cellular uptake and localization of liposomal-methylphosphonate oligodeoxynucleotides", Journal of Molecular Medicine 74, 623-628.
22. Krieg, A., Gmelig-Meyling, F., Gourley, M., Kisch, W., Chrisey, L. and Steinberg, A. (1991) "Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible", Antisense Research and Development 1, 161-171.
23. White, P., Fogarty, R., McKean, S., Venables, D., Werther, G. and Wraight, C. (1999) "Oligonucleotide uptake in cultured keratinocytes: influence of confluence, cationic liposomes, and keratinocyte cell type", The Journal of Investigative Dermatology 112, 699-705.